This Article  • References  • Full text PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Similar articles in this journal

JOHN B. DYNES, M.D.

Arch Neurol Psychiatry. 1939;42(2):248-259.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

Standardized estrogenic preparations have been in use for the past ten years.¹ There is general agreement that these substances are effective in the treatment of disorders of the climacteric, which are evidenced by such symptoms as hot flashes, dizziness, vasomotor imbalance and headache. Gynecologists are agreed that the majority of patients suffering from these menopausal symptoms are relieved, but admit that a few patients benefit little from treatment and that there is no adequate explanation of this failure. There is less agreement among psychiatrists as to the beneficial results of estrogenic therapy for involutional melancholia. Some workers² have been enthusiastic in recommending such treatment, while others³ have reported results which seem to indicate that therapy of this type is not effective in cases of this disorder.

During the early years in which estrogenic substances were given to patients with involutional melancholia, the dose reported seems now, in . . . [Full Text PDF of this Article]

Author Affiliations
BOSTON

From the service of Dr. C. Macfie Campbell, the Boston Psychopathic Hospital.